Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
|
|
Axogen, Inc. (AXGN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/25/2023 |
4
| Burke William P. Mr. (Director) has filed a Form 4 on Axogen, Inc.|
Txns:
| Bought 10,000 shares
@ $6.56, valued at
$65.6k
Granted 6,000 shares
@ $6.31, valued at
$37.9k
|
|
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2023 |
4
| Levine Alan M (Director) has filed a Form 4 on Axogen, Inc.|
Txns:
| Exercised 6,459 restricted stock units
@ $0 |
|
| 06/05/2023 |
4
| JOHNSON JOHN (Director) has filed a Form 4 on Axogen, Inc.|
Txns:
| Exercised 6,459 restricted stock units
@ $0 |
|
| 06/05/2023 |
4
| NEELS GUIDO J (Director) has filed a Form 4 on Axogen, Inc.|
Txns:
| Exercised 6,459 restricted stock units
@ $0 |
|
| 06/05/2023 |
4
| Freitag Gregory Gene (Director) has filed a Form 4 on Axogen, Inc.|
Txns:
| Sold 12,500 shares
@ $8.65, valued at
$108.1k
Sold 29,480 shares
@ $8.74, valued at
$257.7k
Exercised 6,459 restricted stock units
@ $0 |
|
| 06/05/2023 |
4
| Wendell Amy McBride (Director) has filed a Form 4 on Axogen, Inc.|
Txns:
| Exercised 6,459 restricted stock units
@ $0 |
|
| 06/05/2023 |
4
| THOMAS PAUL (Director) has filed a Form 4 on Axogen, Inc.|
Txns:
| Exercised 6,459 restricted stock units
@ $0 |
|
| 05/24/2023 |
4
| Freitag Gregory Gene (Director) has filed a Form 4 on Axogen, Inc.|
Txns:
| Sold 2,828 shares
@ $9.17, valued at
$25.9k
Sold 4,640 shares
@ $9.26, valued at
$43k
|
|
| 05/16/2023 |
4
| Wendell Amy McBride (Director) has filed a Form 4 on Axogen, Inc.|
Txns:
| Exercised 25,000 shares
@ $9.22, valued at
$230.5k
Exercised 3,750 shares
@ $9.22, valued at
$34.6k
Exercised 25,000 options to buy
@ $8.57, valued at
$214.3k
Exercised 3,750 options to buy
@ $8.57, valued at
$32.1k
|
|
| 03/20/2023 |
4
| MARTINEZ MARIA D. (Chief Human Resources Officer) has filed a Form 4 on Axogen, Inc.|
Txns:
| Paid exercise price by delivering 933 shares
@ $8.27, valued at
$7.7k
Paid exercise price by delivering 389 shares
@ $8.27, valued at
$3.2k
Paid exercise price by delivering 1,358 shares
@ $8.27, valued at
$11.2k
Paid exercise price by delivering 1,590 shares
@ $8.27, valued at
$13.1k
Exercised 3,000 restricted stock units
@ $0
Exercised 1,250 restricted stock units
@ $0
Exercised 4,367 restricted stock units
@ $0
Exercised 5,900 restricted stock units
@ $0
Granted 66,500 options to buy
@ $8.27, valued at
$550k
Granted 46,300 options to buy
@ $0 |
|
| 03/20/2023 |
4
| Donovan Michael Patrick (VP Operations) has filed a Form 4 on Axogen, Inc.|
Txns:
| Paid exercise price by delivering 934 shares
@ $8.27, valued at
$7.7k
Paid exercise price by delivering 1,835 shares
@ $8.27, valued at
$15.2k
Exercised 3,000 restricted stock units
@ $0
Exercised 5,900 restricted stock units
@ $0
Granted 63,500 options to buy
@ $8.27, valued at
$525.1k
Granted 48,500 restricted stock units
@ $0 |
|
| 03/20/2023 |
4
| DeVinney Erick Wayne (VP Peripheral Nerve Science) has filed a Form 4 on Axogen, Inc.|
Txns:
| Paid exercise price by delivering 1,835 shares
@ $8.27, valued at
$15.2k
Paid exercise price by delivering 934 shares
@ $8.27, valued at
$7.7k
Exercised 5,900 restricted stock units
@ $0
Exercised 3,000 restricted stock units
@ $0
Granted 64,000 options to buy
@ $8.27, valued at
$529.3k
Granted 46,300 restricted stock units
@ $0 |
|
| 03/20/2023 |
4
| Zaderej Karen L. (CEO) has filed a Form 4 on Axogen, Inc.|
Txns:
| Exercised 25,000 restricted stock units
@ $0
Exercised 12,975 restricted stock units
@ $0
Granted 179,000 options to buy
@ $8.27, valued at
$1.5M
Granted 112,000 restricted stock units
@ $0 |
|
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| MARIANI PETER J (EVP & CFO) has filed a Form 4 on Axogen, Inc.|
Txns:
| Sold 14,111 shares
@ $9.69, valued at
$136.7k
Sold 14,320 shares
@ $9.55, valued at
$136.8k
Sold 14,550 shares
@ $9.36, valued at
$136.2k
Exercised 20,939 options to buy
@ $5.04, valued at
$105.5k
Exercised 20,939 options to buy
@ $5.04, valued at
$105.5k
Exercised 20,940 options to buy
@ $5.04, valued at
$105.5k
|
|
| 01/27/2023 |
4
| MARIANI PETER J (EVP & CFO) has filed a Form 4 on Axogen, Inc.|
Txns:
| Sold 20,939 shares
@ $10.23, valued at
$214.2k
Sold 20,939 shares
@ $9.9, valued at
$207.3k
Sold 20,940 shares
@ $10.16, valued at
$212.8k
Exercised 20,939 options to buy
@ $5.04, valued at
$105.5k
Exercised 20,939 options to buy
@ $5.04, valued at
$105.5k
Exercised 20,940 options to buy
@ $5.04, valued at
$105.5k
|
|
| 12/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2022 |
4
| Billet Isabelle (Chief Strategy and BD Officer) has filed a Form 4 on Axogen, Inc.|
Txns:
| Paid exercise price by delivering 327 shares
@ $9.44, valued at
$3.1k
Exercised 1,150 restricted stock units
@ $0 |
|
| 12/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2022 |
4
| Zaderej Karen L. (CEO) has filed a Form 4 on Axogen, Inc.|
Txns:
| Exercised 4,400 restricted stock units
@ $0 |
|
| 12/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Zaderej Karen L. (CEO) has filed a Form 4 on Axogen, Inc.|
Txns:
| Exercised 26,746 options to buy
@ $5.09, valued at
$136.1k
|
|
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2022 |
4
| Freitag Gregory Gene (Director) has filed a Form 4 on Axogen, Inc.|
Txns:
| Sold 8,886 shares
@ $9.696, valued at
$86.2k
|
|
|
|
|